Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon

Heart valve surgery linked to transient declines in cognitive function

Heart valve surgery patients, including those who undergo aortic and mitral interventions, are at risk of temporary cognitive decline for up to six months after their procedure, according to a study published in the Journal of the American Geriatrics Society this week.

Thumbnail

Researchers develop 1st mini pacemaker capable of long-term mouse studies

Harvard Medical School scientists have created a wirelessly programmed, miniaturized pacemaker which functions for weeks to months at a time, opening the door to “previously impossible investigations of arrhythmia and heart failure in the mouse.”

Thumbnail

Registry study details advancement of CTO interventions in Europe

Experienced operators in Europe are treating chronic total occlusions (CTOs) with increasing procedural success despite attempting more complex lesions over time, according to a report from the European Registry of CTO published in Circulation: Cardiovascular Interventions.

Thumbnail

Longer hospital stays after elective PCI mean higher costs, more readmissions

The shorter a patient’s hospital stay after elective percutaneous coronary intervention (PCI), the better, according to recent research out of the U.K. that linked longer lengths of stay to an increase in unplanned readmissions and healthcare costs.

Thumbnail

Elevated levels of cystatin C linked to 28% increased risk of CVD after ACS

Cystatin C (Cys-C), an alternative to renal markers like creatinine and glomerular filtration rate, can effectively predict a patient’s risk for adverse CVD events after an acute coronary syndrome (ACS), researchers reported Oct. 12 in the Journal of the American Heart Association.

Thumbnail

FDA OKs rivaroxaban for CV event reduction in patients with CAD, PAD

The FDA has approved rivaroxaban to reduce the risk of major cardiovascular events including stroke, myocardial infarction and cardiovascular death for people with chronic peripheral or coronary artery disease (PAD/CAD).

Thumbnail

Researcher urges caution when considering fibrinolytics for elderly STEMI patients

A study presented at TCT 2018 questioned the benefits of “drip-and-ship” for elderly patients with ST-segment elevation myocardial infarction (STEMI), finding patients in their 80s or older who were transferred with fibrinolytic therapy for PCI had an eight-fold risk of hemorrhagic stroke but no survival advantage.

Thumbnail

Antiepileptic drugs boost stroke risk in Alzheimer’s patients

Antiepileptic drugs, regardless of brand or type, increase risk of stroke in seniors diagnosed with Alzheimer’s disease, according to research published in the Journal of the American Heart Association.

Displaying 4273 - 4280 of 10775

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.